Ha habido 50 transacciones internas recientes registradas para HCA Healthcare, Inc. (HCA), incluyendo 13 compras y 29 ventas. El total de compras internas fue valorado en $54.59M y el total de ventas internas en $58.8M.
Internos destacados con actividad reciente incluyen Mcalevey Michael R, Wyatt Christopher F., Berres Jennifer. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — HCA
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-02-18 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Venta Informativa |
1,694 |
$533.38 |
$903.54K |
8,853 |
| 2026-02-13 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Ejercicio de Opciones (Venta) |
5,000 |
$236.61 |
$1.18M |
8,860 |
| 2026-02-11 |
Wyatt Christopher F. |
SVP & Controller |
Venta Informativa |
4,000 |
$505.00 |
$2.02M |
44,379 |
| 2026-02-11 |
Berres Jennifer |
SVP & Chief Human Res. Officer |
Venta Informativa |
4,010 |
$526.17 |
$2.11M |
11,993 |
| 2026-02-10 |
Hazen Samuel N |
CEO |
Retención Fiscal de RSU |
21,323 |
$502.05 |
$10.71M |
64,842 |
| 2026-02-10 |
Foster Jon M |
EVP and COO |
Retención Fiscal de RSU |
5,888 |
$502.05 |
$2.96M |
23,062 |
| 2026-02-10 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
Retención Fiscal de RSU |
3,501 |
$502.05 |
$1.76M |
32,080 |
| 2026-02-10 |
Wyatt Christopher F. |
SVP & Controller |
Retención Fiscal de RSU |
1,034 |
$502.05 |
$519.12K |
48,379 |
| 2026-02-10 |
Berres Jennifer |
SVP & Chief Human Res. Officer |
Retención Fiscal de RSU |
2,515 |
$502.05 |
$1.26M |
20,013 |
| 2026-02-10 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Retención Fiscal de RSU |
3,006 |
$502.05 |
$1.51M |
8,853 |
| 2026-02-10 |
Marks Mike A |
EVP and CFO |
Retención Fiscal de RSU |
1,690 |
$502.05 |
$848.46K |
3,336 |
| 2026-02-10 |
Rossitto Erica |
SVP & Chief Nurse Executive |
Retención Fiscal de RSU |
418 |
$502.05 |
$209.86K |
10,407 |
| 2026-02-06 |
Frist Thomas F Jr |
10 Percent Owner |
Otro (Venta) |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Frist Thomas F Iii |
10 Percent Owner |
Otro (Venta) |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Hercules Holding Ii |
10 Percent Owner |
Otro (Venta) |
36,629,188 |
- |
- |
32,282,889 |
| 2026-02-06 |
Frisco Holding Ii |
10 Percent Owner |
Otro (Venta) |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Elcan Patricia F |
10 Percent Owner |
Otro (Venta) |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-06 |
Frist William R |
10 Percent Owner |
Otro (Venta) |
36,629,188 |
$0.01 |
$366.29K |
- |
| 2026-02-05 |
Foster Jon M |
EVP and COO |
Ejercicio de Opciones (Venta) |
29,330 |
$139.06 |
$4.08M |
- |
| 2026-02-05 |
Wyatt Christopher F. |
SVP & Controller |
Ejercicio de Opciones (Venta) |
10,670 |
$139.06 |
$1.48M |
- |
| 2026-02-04 |
Hazen Samuel N |
CEO |
Otro (Compra) |
1,045 |
$498.35 |
$520.78K |
16,024 |
| 2026-02-03 |
Hazen Samuel N |
CEO |
Venta Informativa |
120 |
$497.18 |
$59.66K |
32,276 |
| 2026-02-03 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
Donación (Otorgada) |
4,050 |
- |
- |
25,953 |
| 2026-02-01 |
Rossitto Erica |
SVP & Chief Nurse Executive |
Desconocido |
960 |
$130.56 |
$125.34K |
- |
| 2026-01-30 |
Hazen Samuel N |
CEO |
Ejercicio de Opciones (Venta) |
84,360 |
$81.96 |
$6.91M |
- |
| 2026-01-29 |
Hazen Samuel N |
CEO |
Concesión de RSU |
55,846 |
$482.53 |
$26.95M |
55,846 |
| 2026-01-29 |
Foster Jon M |
EVP and COO |
Concesión de RSU |
11,945 |
$482.53 |
$5.76M |
11,945 |
| 2026-01-29 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
Concesión de RSU |
8,067 |
$482.53 |
$3.89M |
8,067 |
| 2026-01-29 |
Wyatt Christopher F. |
SVP & Controller |
Concesión de RSU |
2,560 |
$482.53 |
$1.24M |
2,560 |
| 2026-01-29 |
Berres Jennifer |
SVP & Chief Human Res. Officer |
Concesión de RSU |
6,206 |
$482.53 |
$2.99M |
6,206 |
| 2026-01-29 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Concesión de RSU |
8,067 |
$482.53 |
$3.89M |
8,067 |
| 2026-01-29 |
Marks Mike A |
EVP and CFO |
Concesión de RSU |
11,945 |
$482.53 |
$5.76M |
11,945 |
| 2025-11-14 |
Hazen Samuel N |
CEO |
Donación (Otorgada) |
14,830 |
- |
- |
32,276 |
| 2025-11-05 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Venta Informativa |
3,892 |
$473.79 |
$1.84M |
3,487 |
| 2025-11-05 |
Marks Mike A |
EVP and CFO |
Donación (Otorgada) |
165 |
- |
- |
- |
| 2025-11-03 |
Mcalevey Michael R |
EVP & Chief Legal & Admin Off. |
Ejercicio de Opciones (Venta) |
13,170 |
$236.61 |
$3.12M |
- |
| 2025-11-03 |
Marks Mike A |
EVP and CFO |
Donación (Recibida) |
165 |
- |
- |
165 |
| 2025-10-31 |
Hazen Samuel N |
CEO |
Ejercicio de Opciones (Venta) |
58,050 |
$69.58 |
$4.04M |
- |
| 2025-09-08 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
Venta Informativa |
3,836 |
$418.84 |
$1.61M |
31,503 |
| 2025-09-04 |
Cuffe Michael S. |
EVP and Chief Clinical Officer |
Ejercicio de Opciones (Venta) |
10,920 |
$173.12 |
$1.89M |
10,000 |
| 2025-07-29 |
Chidsey John |
Director |
Concesión de RSU |
496 |
- |
- |
496 |
| 2025-07-15 |
Chidsey John |
Director |
Desconocido |
- |
- |
- |
3 |
| 2025-05-13 |
Hazen Samuel N |
CEO |
Donación (Otorgada) |
90,076 |
- |
- |
- |
| 2025-05-13 |
Foster Jon M |
EVP and COO |
Otro (Venta) |
15,925 |
$367.20 |
$5.85M |
- |
| 2025-05-07 |
Marks Mike A |
EVP and CFO |
Otro (Venta) |
285 |
$356.84 |
$101.7K |
- |
| 2025-05-06 |
Marks Mike A |
EVP and CFO |
Donación (Otorgada) |
144 |
- |
- |
144 |
| 2025-04-30 |
Frist William R |
10 Percent Owner |
Otro (Compra) |
10,505 |
$340.60 |
$3.58M |
1,574,897 |
| 2025-04-29 |
Deparle Nancy Ann |
Director |
Concesión de RSU |
645 |
- |
- |
21,401 |
| 2025-04-29 |
Michelson Michael W |
Director |
Concesión de RSU |
1,173 |
- |
- |
11,651 |
| 2025-04-29 |
Frist Thomas F Iii |
10 Percent Owner |
Concesión de RSU |
1,320 |
- |
- |
14,817 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
